¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"NITROGLYCERIN HNA SUB."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® nitroglycerin ÇÑ±Û ´ÏÆ®·Î±Û¸®¼¼¸°
¼³¸í   
  °­·ÂÇÑ Ç÷°üÀÌ¿ÏÀÛ¿ë°ú ±ÙÀ°¾ïÁ¦ÀÛ¿ëÀ» ¹ß»ý½ÃÄÑ, Ç÷¾ÐÀ» Çϰ­½Ã۰í, ½ÉÀå¿¡ ´ëÇÑ Áö³ªÄ£ ¿îµ¿ºÎÇϸ¦ °¨¼Ò½ÃŰ¹Ç·Î, Çù½ÉÁõ µî¿¡¼­ ±Þ¼º¹ßÀ۽ÿ¡ »ç¿ëÇÑ´Ù. ´ÏÆ®·¹ÀÌÆ®´Â ÀÌ·± ÀÛ¿ëÀ» Çϴ ¿©·¯ ¾àÀ» ÅëĪÇÏ¿© ºÎ¸£´Â ¸»À̸ç, ´ëÇ¥ÀûÀΠ¾àÁ¦·Î NitroglycerinÀÌ Á¸ÀçÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nitroglycerin
    ´ÏÆ®·Î±Û¸®¼¼¸°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nitroglycerin
    ´ÏÆ®·Î±Û¸®¼¼¸°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nitroglycerin
    ´ÏÆ®·Î±Û¸®¼¼¸°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • haemorrhagia sub coitu ³ª
    ¼º±³(àõÎß)ÃâÇ÷.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nitroglycerin
    ´ÏÆ®·Î±Û¸®¼¼¸°.
  • cisternae subarachnoideales =sub aracho ni dal ciscerns<³ª>
    °Å¹Ì¸·¼öÁ¶, °Å¹Ì¸·ÇÏÁ¶(¡­Ø¯ù»ðË).
  • dolor sub coitu<³ª>
    ¼º±³µ¿Åë(àõÎßÔÙ÷Ô).
  • haemorrhagia sub coitu ³ª
    ¼º±³(àõÎß)ÃâÇ÷.
  • sub partum
    ºÐ¸¸ÁßÀÇ.
  • sub-supracardinal anastomosis
    ¾Æ·¡À§±âº»Á¤¸Æ¿¬°á
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Sub-supracardinal anastomosis
    ¾Æ·¡À§±âº»Á¤¸Æ¿¬°á
    [¿¾ ¿ë¾î] ÇÏ»óÁÖÁ¤¸Æ¹®ÇÕ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nitroglycerin
    ´ÏÆ®·Î±×¸®¼¼¸°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
S.C. Sub Cutis; Sub-Cutaneous(ly) injection; ÇÇÇÏ·Î, ÇÇÇÏÁÖ»ç
HNA heparin neutralizing activity
NG nasogastric; neoplastic growth; new growth; nitroglycerin; nodose ganglion; no growth; not given
nitro nitroglycerin
NTG nitroglycerin; nitrosoguanidine; nontoxic goiter; normal triglyceridemia
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
sub-MIC sub-minimal inhibitory concentration
sub-MIC sub-minimum inhibitory concentration
HNA Heparin neutralizing activity
HNA Hereditary Neuralgic Amyotrophy
NG Nitroglycerin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • NADPH oxidase NADPH+2O2=NADP+ +2O2-ÀÇ È­ÇйÝÀÀÀ» Ã˸ÅÇÏ´Â »êÈ­ ȯ¿ø È¿¼ÒÀÇ ÇÑ Á¾·ùÀÌ´Ù. ÀÌ È¿¼Ò°èÀÇ À¯ÀüÀû °áÇÌÀº ¸¸¼º À°¾ÆÁ¾¼º ÁúȯÀ» À¯¹ßÇÑ´Ù.

    Nadsonieae

    ³ªµå¼Ò´Ï¾ÆÁ·
    È¿¸ð±Õ¾Æ°ú SaccharomycetoideaeÀÇ 1Á·À¸·Î, ±Õ»ç°¡ ¾ø°í, ·¹¸ó¸ð¾çÀÇ ºÐ¾Æ¼¼Æ÷°¡ ¹ß»ýÇÑ´Ù.
  • F1 anti-parental cytotoxicity
    F1 Ç× ¾çÄ£ ¼¼Æ÷ »óÇØ, F1 Ç× ¾çÄ£ ¼¼Æ÷ µ¶¼º
    in vivo¿¡¼­ F
  • F1 hybrid disease
    F1 ÇÏÀ̺긮µå Áúȯ
    ÇÑÂÊ ¾î¹öÀÌÀÇ ¸é¿ª ´ã´ç ¼¼Æ÷¸¦ F
  • F2 anti-parental cytotoxicity
    F2 Ç× ¾çÄ£ ¼¼Æ÷ »óÇØ
    in vitro¿¡¼­ F
  • Q02
    »ê¼Ò Èí¼ö·Â
    Á¶Á÷ 1 mg ´ç 1 ½Ã°£¿¡ Èí¼öµÈ »ê¼ÒÀÇ ¹ÌÅ©·Î¹ÌÅͼö·Î, ½À°ü»ó ºÎÀÇ ¼öÄ¡·Î Ç¥½ÃÇÑ´Ù.
  • Vmax
    ÃÖ´ë ¹ÝÀÀ ¼Óµµ
    È¿¼Ò Ã˸йÝÀÀÀÇ ÃÖ´ë ¼Óµµ¸¦ ³ªÅ¸³»´Â ±âÈ£.
  • VT (ÀÏȸ ȯ±â·®) Æó ȯ±â¿¡ À־ tidal volumeÀ» ³ªÅ¸³»´Â ±âÈ£.

    vulcanite

    À¯È­°í¹«
  • nitroglucose : µ¿ÀǾî=nitrodextrose.

    nitroglycerin

    ´ÏÆ®·Î ±Û¸®¼¼¸°, Áú»ê¿°
    C3H5N3O9. ¹«»ö ³»Áö Ȳ»ö ¾×ü·Î Áú»ê°ú Ȳ»êÀÌ ±Û¸®¼¼¸°¿¡ ÀÛ¿ëÇØ Çü¼ºµÈ´Ù. ÁøÅÁ¿¡ ÀÇÇØ¼­ Æø¹ßµÇÁö¸¸ ¸¸´ÏÅç°ú È¥ÇÕÇÑ Á¤Á¦´Â ¾ÈÀüÇÏ´Ù. °øÀÎµÈ Á¦Á¦´Â ÀÇÇпëÀ¸·Î¼­ ÁÖ·Î Çù½ÉÁõ ¿¹¹æ ºû Ä¡·á¿¡ »ç¿ëµÇ¸ç, ¼³ÇÏ·Î Åõ¿©ÇÑ´Ù.
  • sub-supracardinal anastomosis
    ¾Æ·¡ À§ ±âº» Á¤¸Æ ¿¬°á
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
sub- 1. <prefix> A prefix signifying under, below, beneath, and hence often, in an inferior position or degree, in an imperfect or partial state, as in subscribe, substruct, subserve, subject, subordinate, subacid, subastringent, subgranular, suborn. Sub- in Latin compounds often becomes sum- before m, sur before r, and regularly becomes suc-, suf-, sug-, and sup- before c, f, g, and p respectively. Before c, p, and t it sometimes takes form sus- (by the dropping of b from a collateral form, subs-).
2. <chemistry> A prefix denoting that the ingredient (of a compound) signified by the term to which it is prefixed,is present in only a small proportion, or less than the normal amount; as, subsulphide, suboxide, etc. Prefixed to the name of a salt it is equivalent to basic; as, subacetate or basic acetate.
Origin: L. Sub under, below; akin to Gr, Skr. Upa to, on, under, over. Cf. Hypo-, Super-.
(29 Oct 1998)
nitroglycerin <chemistry> A liquid appearing like a heavy oil, colourless or yellowish, and consisting of a mixture of several glycerin salts of nitric acid, and hence more properly called glycerin nitrate.
It is made by the action of nitric acid on glycerin in the presence of sulphuric acid. It is extremely unstable and terribly explosive. A very dilute solution is used in medicine as a neurotic under the name of glonion.
A great number of explosive compounds have been produced by mixing nitroglycerin with different substances; as, dynamite, or giant powder, nitroglycerin mixed with siliceous earth; lithofracteur, nitroglycerin with gunpowder, or with sawdust and nitrate of sodium or barium; Colonia powder, gunpowder with nitroglycerin; dualin, nitroglycerin with sawdust, or with sawdust and nitrate of potassium and some other substances; lignose, wood fibre and nitroglycerin.
Pharmacologic action: Relaxes smooth muscle - dilates veins, dilates coronary arteries, reduces left ventricular filling pressure, lowers systemic vascular resistance, decreases myocardial oxygen demand.
Uses: Treat angina pectoris.
Dose: One tablet (0.3 to 0.4 mg) sublingual, may repeat twice at 5 minute intervals Intravenous infusion: 0.5 - 2 mcg/kg per min.
Potential complications: May cause hypotension, especially if hypovolemic; headache is common.
Alternative forms: nitroglycerine.
Origin: Nitro- + glycerinn.
(17 Mar 2000)
nitroglycerin reductase <enzyme> Pseudomonas fmn-containing enzyme that catalyses NADPH-dependent denitration of nitroglycerin, yielding nitrite
Registry number: EC 1.7.99.-
(26 Jun 1999)
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 1 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
Çϳª´ÏÆ®·Î±Û¸®¼¼¸°¼³ÇÏÁ¤0.6mg - »õâ
ÇϳªÁ¦¾à
A20450521 Nitroglycerin
Àü¹®ÀǾàǰ | ±Þ¿©
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nitroglycerin
    ´ÏÆ®·Î±Û¸®¼¼¸°
  • sub rosa
    ³²¸ô·¡
  • sub-
    ¾Æ·¡ÀÇ
  • A-sub
    ¿øÀÚ·Â Àá¼öÇÔ
  • railway sub-office
    öµµ ¿ìÆí Áö±¹
  • sub
    ÇÏÀ§ÀÇ
  • sub
    º¸Ãæ¿ø;º¸°á ¼±¼ö;Àá¼öÇÔ;ÁßÀ§;¼ÒÀ§
  • sub
    ´ë½ÅÇÏ´Ù;´ë¸®¸¦ º¸´Ù
  • sub finum
    (ÂüÁ¶ÇÒ Àå Àý µûÀ§ÀÇ)¸»¹Ì¿¡ (»ý·« s,f;)
  • sub judice
    ½É¸® ÁßÀÇ;¹Ì°áÀÇ
  • sub rosa
    ºñ¹ÐÈ÷
  • sub voce
    ...ÀÇ Ç׿¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á